Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Series A
founded in
2021
Photys Therapeutics is a biotechnology company that specializes in developing proprietary bifunctional small molecules aimed at controlling protein post-translational modifications. Their innovative platform goes beyond traditional degradation methods to restore protein function, repair signaling pathways, and enhance the body's natural disease-fighting mechanisms. Co-founded by leading experts from the Broad Institute and supported by a distinguished scientific advisory board, Photys Therapeutics is positioned to make significant advancements in precision medicine, particularly in modulating and repairing disease-driving proteins. The company has garnered attention and funding to further its research and development efforts in this promising field.
Something looks off?